InMode/$INMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About InMode
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Ticker
$INMD
Sector
Primary listing
Employees
660
Headquarters
Yokne'am, Israel
Website
InMode Metrics
BasicAdvanced
$930m
10.81
$1.36
1.98
-
Price and volume
Market cap
$930m
Beta
1.98
52-week high
$16.74
52-week low
$12.72
Average daily volume
884k
Financial strength
Current ratio
8.801
Quick ratio
7.47
Long term debt to equity
0.73
Total debt to equity
0.73
Profitability
EBITDA (TTM)
80.521
Gross margin (TTM)
77.84%
Net profit margin (TTM)
23.27%
Operating margin (TTM)
21.31%
Effective tax rate (TTM)
14.69%
Revenue per employee (TTM)
$570,000
Management effectiveness
Return on assets (TTM)
6.86%
Return on equity (TTM)
13.62%
Valuation
Price to earnings (TTM)
10.806
Price to revenue (TTM)
2.48
Price to book
1.41
Price to tangible book (TTM)
1.41
Price to free cash flow (TTM)
10.862
Free cash flow yield (TTM)
9.21%
Free cash flow per share (TTM)
1.351
Growth
Revenue change (TTM)
-4.53%
Earnings per share change (TTM)
-40.75%
3-year revenue growth (CAGR)
-7.57%
3-year earnings per share growth (CAGR)
-12.10%
What the Analysts think about InMode
Analyst ratings (Buy, Hold, Sell) for InMode stock.
InMode Financial Performance
Revenues and expenses
InMode Earnings Performance
Company profitability
InMode News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs